Juan José Lasarte

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata et al. · Journal of Hepatology · 2013 · 988 citations

Medicine, Oncology, Pharmacology +15

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Yuting Ma, Laetitia Aymeric, Clara Locher et al. · The Journal of Experimental Medicine · 2011 · 326 citations · Full text

Life Sciences, Immunology, Oncology +17

Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression

Leticia Corrales, Daniel Ajona, Stavros Rafail et al. · The Journal of Immunology · 2012 · 279 citations · Full text

Medicine, Immunology, Oncology +13

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Daniel Ajona, Sergio Ortiz‐Espinosa, Haritz Moreno et al. · Cancer Discovery · 2017 · 255 citations

Medicine, Oncology, Pharmacology +17

CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination

Noëlia Casares, Laura Arribillaga, Pablo Sarobe et al. · The Journal of Immunology · 2003 · 191 citations · Full text

Life Sciences, Immunology, Oncology +17